Table of Contents Table of Contents
Previous Page  21 / 24 Next Page
Information
Show Menu
Previous Page 21 / 24 Next Page
Page Background

Bouffet et al. J Clin Oncol 2016; 34: 2206-2211

Inmunoterapia y biomarcadores: nivolumab